BIS Research

MARCH 19, 2019

As on date, the burgeoning economic burden due to the increasing incidence of chronic diseases, such as cancer is paving the way for precision medicine market. The market is projected to witness a CAGR of 10.56% during the forecast period from 2018 to 2028. billion in 2018 and is expected to reach $216.75 billion by 2028.

Globalization 64

Globalization Biotech Marketing Marketing 64

IT Business Edge

JULY 12, 2022

Also read: Top 7 Data Management Trends to Watch in 2022. Andressen Horowitz hired specialists to help entrepreneurs with many parts of their business, such as PR, sales, marketing, and design. With Imply, it has focused on the large market for developers building analytics applications. Andreessen Horowitz. Lightspeed.

Startups 101

Startups Capital Biotech Finance 101

Alpha Sense BI

MAY 5, 2023

2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech.

Biotech 97

Biotech Capital Banking Startups 97

Wink Intel

FEBRUARY 23, 2021

Each index was chosen for specific qualities, helping provide diverse allocation strategy options as different markets react to different market conditions,” said American Equity President Ron Grensteiner. By balancing risk and then seeking returns, this index aims to provide stable returns in many market environments.”.

Intellectual Property 40

Intellectual Property Biotech Banking Retail 40

Alpha Sense BI

APRIL 29, 2024

Over the last couple of years, funding activity has been affected by nearly a dozen interest rate hikes by the Federal Reserve Bank, the highest record inflation in four decades, market volatility, and fading valuations. While dry powder experienced a run in 2021, venture capital investment in the U.S.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. Below, we dive into the key trends that will shape the technology landscape in upcoming quarters and share the key insights that will keep you ahead of the market. OpenAI’s ChatGPT ).

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

JANUARY 26, 2024

GLP-1 Agonists and Precision Medicines It’s no surprise that GLP-1 agonists—a class of medications that can help manage Type 2 diabetes and obesity—took center stage at the Conference. The market leader, Novo Nordisk, is already strategizing the next phases for its obesity drug, Wegovy. Sign up for your free trial today.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Alpha Sense BI

APRIL 12, 2024

AlphaSense, a leading artificial intelligence (AI)-based market intelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. Market Perception Errors – There are cases in which financial analysts misunderstand the health of a business.

Primary Research 52

Primary Research Advantage Advantage Research 52

Engage3

MAY 19, 2022

Ken Ouimet, PhD Founder/Chairman, Technology Committee Ken Ouimet is the Chair of Strategic Planning and Founder of Engage3 and is credited with creating the retail revenue management and price optimization market. Khimetrics provided the highest value point solution on the market and helped retailers roughly double their net profits.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

NOVEMBER 9, 2022

Given the state of the market, macro influences at play, and consensus forecasts covering a wide spectrum, the results this season are sure to uncover insights that could indicate broader market shifts. month, as well as in 11 other markets. Management is guiding to 4Q net adds of +4.5 million, revenue guidance of $7.78

Sales 52

Sales Loss Capital Biotech 52

CIO

JULY 17, 2023

Many IT leaders today are focused more on security management as well as improving IT operations and systems performance than they are on top-line and strategic activities such as driving business innovation, identifying competitive differentiation opportunities, and even working on business strategy.

Biotech 617

Biotech Innovation Technology Technology 617

Alpha Sense BI

MARCH 4, 2024

Increasingly, artificial intelligence (AI) is transforming the delivery and speed of pharmaceutical drugs to the market. With a total addressable market of nearly $50 billion for AI-enabled drug development, it is estimated that 30% of new drugs will be discovered using AI by 2025.

Biotech 52

Biotech Pharmaceutical Intelligence Intelligence 52

Alpha Sense BI

MARCH 13, 2024

The healthcare sector , like others, has faced headwinds such as soaring interest rates, steep inflation, FTC regulatory challenges, post-pandemic supply chain issues, and market volatility that have flattened M&A deals.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Happy Market

MAY 9, 2022

Their proprietary InsightStore analyzes the responses so decision-makers can discover the market and cultural trends. This Episode is Sponsored by: The Michigan State University’s Master of Science in Marketing Research Program delivers the #1 ranked insights and analytics graduate degree in three formats: Full-time on campus.

Management 52

Management Entertainment Market Research Marketing Research 52

Alpha Sense BI

MARCH 28, 2023

Industry developments and market movements often feel endless, making it difficult to stay at the forefront of your industry. These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their market research, landscaping, and monitoring.

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52